Literature DB >> 9004467

Immunoprophylactic intervention in chemical toxicity and carcinogenicity.

L K Silbart1, M V Rasmussen, A R Oliver.   

Abstract

Preventing or diminishing the effects of environmental carcinogens and toxicants using immunoprophylactic vaccines has been tested by various investigators for the last 60 y. This approach has not gained widespread interest in scientific or medical communities due to ambiguous results. However, advances in vaccine design and immunization protocols now offer a reliable mechanism for the induction of mucosal immunity which may afford protection from these agents at their site of absorption. Previous studies aimed at immunoprophylactic vaccination against carcinogens and toxicants are reviewed, and future directions for this area of research are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9004467

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  5 in total

1.  Immunogenicity of a promiscuous T cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the hapten.

Authors:  Mario T Schellenberger; Nathalie Grova; Sophie Farinelle; Stéphanie Willième; Dominique Revets; Claude P Muller
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

2.  A novel approach to the development of anticarcinogenic vaccines.

Authors:  A N Glushkov; S V Apalko; M L Filipenko; V A Matveeva; A Yu Bakulina; V G Lunin; M V Kostyanko
Journal:  Acta Naturae       Date:  2010-10       Impact factor: 1.845

3.  Postmenopausal Breast Cancer Risk in Relation to Antibodies Specific to Benzo[a]Pyrene, Estradiol and Progesterone.

Authors:  Andrew Glushkov; Elena Polenok; Mikhail Kostyanko; Alexandr Antonov; Natalia Verzhbitskaya; Ilgiz Vafin; Svetlana Ragozhina
Journal:  Iran J Cancer Prev       Date:  2016-04-24

Review 4.  Immunomodulation of carcinogens-induced steroids-dependent human diseases.

Authors:  Andrew N Glushkov; Elena G Polenok
Journal:  Saudi J Biol Sci       Date:  2017-10-03       Impact factor: 4.219

5.  Cloning and characterization of a hybridoma secreting a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-specific monoclonal antibody and recombinant F(ab).

Authors:  Heather Wanczyk; Tolga Barker; Debra Rood; Daniel I Zapata; Amy R Howell; Stewart K Richardson; John Zinckgraf; Gregory P Marusov; Michael A Lynes; Lawrence K Silbart
Journal:  Toxins (Basel)       Date:  2013-03-19       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.